Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-17 Sale | 2024-12-18 4:14 pm | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 3,245 | $2.424 | $7,866 | 240,691 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-14 Option Award | 2024-03-15 4:32 pm | N/A 2034-03-14 | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 370,000 | $0 | 443,936 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-15 09:21 am | N/A 2033-03-14 | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 48,200 | $0 | 112,936 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-12 4:07 pm | N/A 2032-12-09 | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 110,000 | $0 | 129,771 (Direct) | View |
Ownership | 2022-11-16 4:11 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer | 0 | $0 | 19,771 (Direct) | View |